• Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    R.I. Yatsyshyn, P.R. Herych, O.M. Didushko, O.A. Shapoval


    About the author: R.I. Yatsyshyn, P.R. Herych, O.M. Didushko, O.A. Shapoval
    Type of article Scentific article
    Annotation Study of the possibility to correct endothelial dysfunction (ED), structural changes in peripheral arteries and synthesis of metabolic-waste products of nitric oxide (NO) (nitrites NO_2^- / nitrates NO_3^-) by means of including the combination of roflumilast and quercetin to the background therapy has been investigated. In 6 months, the use of complex therapy, in contrast to the background one, has resulted in a statistically significant increase of the initial rate by 18.76% from (0.61 ± 0.04) m/s to (0.75 ± 0.04) m/s (t=2.47; p<0.05) and in a statistically significant decrease of the initial diameter of a brachial artery to 3.74 ± 0.28 mm (t=2.49; p<0.05). Administration of complex therapy after 6 months has showed that the concentration of NO metabolites in the blood has gone up 1.3 times, up to 10.35 ± 1.89 mcmole/l (t=1.00; p>0.1) with the norm of 12.05 ± 2.11 mcmole/l. Administration of complex therapy for patients with a severe stage of chronic obstructive pulmonary disease (COPD) in an exacerbation phase accompanied with a stable coronary artery disease and stable effort angina (SCAD SEA) of the 2nd FC helps restore endothelial function, improves peripheral arterial structural changes and has a stimulating effect on the synthesis of NO.
    Tags stable coronary artery disease, chronic obstructive pulmonary disease, endothelial dysfunction, oxidative stress
    • Berezin AE. Terapevticheskiy potentsial α-lipoievoi (tioktovoi) kisloty pri kardiovaskuliarnykh zabolievaniiakh. Ukr. med. chasopys. 2017; 2(118): 95-98. [in Russian]
    • Berezin AE. Proteiny vnekletochnogo matrixa kak biomarkery vaskuliarnogo remodilirovaniia i kardiovaskuliarnukh klinicheskikh iskhodov. Ukr. med. chasopys. 2015; 6(110): 58-64. [in Russian]
    • Astuti RI, Nasuno R, Takagi H. Nitric oxide signaling in yeast. Appl. Microbiol. Biotechnol. 2016; 100(22): 9483-9497.
    • Byon CH, Heath JM, Chen Y. Redox signaling in cardiovascular pathophysiology: a focus on hydrogen peroxide and vascular smooth muscle cells. Redox. Biol. 2016; 9: 244-253.
    • Chen Z, Liu X, Ma S. The Roles of Mitochondria in Autophagic Cell Death. Cancer Biother. Radiopharm. 2016; 31(8):
    • 269-276.
    • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Pocket guide to COPD diagnosis, management and prevention: a guide for health care professionals. 2016. Available at: http://www.goldcopd.org/ (accessed 02/07/09).
    • Gnudi L, Coward RJ, Long DA. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms. Trends Endocrinolog. Metab. 2016; 27(11): 820-830.
    • Zhu J, Wang H, Chen F. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy. Free Radic Biol. Med. 2016; 99: 544-556.
    • Kurundkar A, Thannickal VJ. Redox mechanisms in age-related lung fibrosis. Redox Biol. 2016; 9: 67-76.
    • Redza-Dutordoir M, Averill-Bates D. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim. Biophys. Acta. 2016; 1863(12): 2977-2992.
    • Regina C, Panatta E, Candi E. Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases. Mech. Ageing Dev. 2016; l(159): 14-21.
    Publication of the article «World of Medicine and Biology» №1(67), 2019 year, 121-125 pages, index UDK 616-08+615.276+616.24+616.12-009.72
    DOI 10.26724/2079-8334-2019-1-67-121